Gene · 26585
Papers2,742
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,742
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Aberrant expression of Gremlin1 induces trophoblast senescence in the placenta of advanced maternal age pregnancy. | J Transl Med | 2026 | 42204611 | PubTator, text mining | PubMed |
| Non-Syndromic or Anomaly-Associated Genes (MYH3, GREM1, IRF6) and Their Proteins in Unilateral Right Cleft Tissue. | Int J Mol Sci | 2026 | 42196143 | PubTator, text mining | PubMed |
| An integrated single-cell and spatial proteotranscriptomics atlas of fibroblast-driven immunoregulation within the human adult oral cavity. | Cell Press Blue | 2026 | 42147490 | PubTator, text mining | PubMed |
| Integrated transcriptomic and proteomic analyses identify novel biomarkers of bladder outlet obstruction. | bioRxiv | 2026 | 42146350 | PubTator, text mining | PubMed |
| Immunotherapies based on macrophage reprogramming in periodontitis and apical periodontitis. | Clin Oral Investig | 2026 | 42133106 | PubTator, text mining | PubMed |
| A dose-finding population pharmacokinetic/pharmacodynamic model of ginisortamab, an anti-gremlin-1 monoclonal antibody, in patients with solid tumours. | Br J Clin Pharmacol | 2026 | 42063284 | PubTator, text mining | PubMed |
| Impact of smoking on gremlin-1, syndecan-4, and IL-1β responses to non-surgical periodontal therapy in stage 3 periodontitis: a comparative study with periodontally healthy controls. | Clin Oral Investig | 2026 | 41964715 | PubTator, text mining | PubMed |
| From QI-disability to QID-12: creating a brief proxy-report measure of quality of life for children with intellectual disability. | Qual Life Res | 2026 | 41920472 | PubTator, text mining | PubMed |
| Impaired bone matrix turnover with selective small bone fragility in a child with TENT5A-associated osteogenesis imperfecta. | JBMR Plus | 2026 | 41908159 | PubTator, text mining | PubMed |
| Advances in Spatial Multi-Omics in Gastric Cancer. | Cells | 2026 | 41892326 | PubTator, text mining | PubMed |
| GREM1 acts in leptin receptor-expressing skeletal cells to mediate peri-implant fibrosis. | Nat Commun | 2026 | 41872191 | PubTator, text mining | PubMed |
| Adipogenic transdifferentiation reprograms EMT-high PDAC cells into a post-mitotic adipocyte-like state and limits metastasis. | Cell Death Dis | 2026 | 41862438 | PubTator, text mining | PubMed |
| Targeting BMP2 signaling pathway in osteogenesis and osteoarthritis: A path toward safer regenerative therapies. | Cell Signal | 2026 | 41833768 | PubTator, text mining | PubMed |
| Constructing a protein-protein interaction network for autoimmune liver diseases by integrating pQTL, rQTL, and mediation analyses. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | 41814035 | PubTator, text mining | PubMed |
Integrative Mendelian Randomization and Pathomics Analysis Using Expression Quantitative Trait Loci and Genome-Wide Association Study Data Identifies Mismatch Repair Genes as Prognostic Biomarkers in Gastric Adenocarcinoma. | Int J Genomics | 2026 | 41809732 | PubTator, text mining | PubMed |
| Pro-Homeostatic Effects of Estrogen on Intraocular Pressure and the Trabecular Meshwork. | Invest Ophthalmol Vis Sci | 2026 | 41800843 | PubTator, text mining | PubMed |
| Tumor-Induced Rewiring of Splenic Niches: from Immune Organ to Cancer Accomplice. | Int J Biol Sci | 2026 | 41800261 | PubTator, text mining | PubMed |
| Advances in Targeted and Immunotherapy for High-Risk Cutaneous Malignancies. | Oncol Res | 2026 | 41799519 | PubTator, text mining | PubMed |
| RNA N4-acetylcytidine modification in human cancers: from molecular function to oncogenic mechanisms. | iScience | 2026 | 41797923 | PubTator, text mining | PubMed |
| Gremlin-1 promotes leukemic survival via PI3K/AKT signaling in infant MLL-AF4-positive B-cell acute lymphoblastic leukemia. | Exp Hematol | 2026 | 41759887 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/26585/papers?page=2